CSL Outlines Growth Strategy Following Vifor Acquisition
CSL [ASX:CSL] released an investor briefing presentation on Monday, providing further detail on its Vifor acquisition, along with a business and strategy update. CSL believes its recent US$11.7 billion acquisition of iron deficiency business Vifor will accelerate the company’s growth by bulking up its product pipeline, even if questions over ‘IP cliffs’ remain. CSL shares […]





